Per Grybäck

5PUBLICATIONS
44CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)BacteriologyPredictive and prognostic markersCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Apr 08, 2026
Neoadjuvant palbociclib and endocrine therapy versus chemotherapy in ER + /HER2- breast cancer: a randomized phase II trial.

Alexios Matikas, Evangelos Tzoras, Michail Sarafidis

|Sep 24, 2025
Refined Lactulose Hydrogen Breath Test for Small Intestinal Bacterial Overgrowth Subgrouping Irritable Bowel Syndrome With Low and High Breath Hydrogen.

A Dahlgren, P Grybäck, H Jacobsson

|Jun 07, 2023
Primary tumour iodine avidity in relation to uptake in persistent metastatic disease in papillary and poorly differentiated thyroid cancer.

Joachim N Nilsson, Per Grybäck, C Christofer Juhlin

|Apr 21, 2023
Sentinel node-assisted neck dissection in advanced oral squamous cell carcinoma-A new protocol for staging and treatment.

Rusana Bark, Aeneas Kolev, Alexandra Elliot

|Nov 30, 2022
Survival Outcomes, Digital TILs, and On-treatment PET/CT During Neoadjuvant Therapy for HER2-positive Breast Cancer: Results from the Randomized PREDIX HER2 Trial.

Alexios Matikas, Hemming Johansson, Per Grybäck

Pageof 1

Frequent Collaborators

2 joint publications

Theodoros Foukakis

2 joint publications

Alexios Matikas

2 joint publications

Jonas Bergh

2 joint publications

Balazs Acs